Zevra Therapeutics (FRA:1GDA) Days Payable : 873.80 (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Zevra Therapeutics Days Payable?

Zevra Therapeutics's average Accounts Payable for the three months ended in Dec. 2024 was €12.49 Mil. Zevra Therapeutics's Cost of Goods Sold for the three months ended in Dec. 2024 was €1.30 Mil. Hence, Zevra Therapeutics's Days Payable for the three months ended in Dec. 2024 was 873.80.

The historical rank and industry rank for Zevra Therapeutics's Days Payable or its related term are showing as below:

FRA:1GDA' s Days Payable Range Over the Past 10 Years
Min: 149.79 Med: 494.75 Max: 3392.69
Current: 665.88

During the past 12 years, Zevra Therapeutics's highest Days Payable was 3392.69. The lowest was 149.79. And the median was 494.75.

FRA:1GDA's Days Payable is ranked better than
82.01% of 706 companies
in the Biotechnology industry
Industry Median: 118.245 vs FRA:1GDA: 665.88

Zevra Therapeutics's Days Payable declined from Dec. 2023 (1,039.41) to Dec. 2024 (873.80). It may suggest that Zevra Therapeutics accelerated paying its suppliers.

Zevra Therapeutics Days Payable Historical Data

The historical data trend for Zevra Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zevra Therapeutics Days Payable Chart

Zevra Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

338.64

142.43

3,359.74

1,486.65

652.21

Zevra Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial															1,039.41	7,269.39	-	-	873.80

Competitive Comparison of Zevra Therapeutics's Days Payable

For the Biotechnology subindustry, Zevra Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zevra Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zevra Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Zevra Therapeutics's Days Payable falls into.

Save Embed

;

Save Embed

;

Zevra Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Zevra Therapeutics's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (12.826	+	12.487)	/	2 )	/	7.083	*	365
=	12.6565					/	7.083	*	365
=	652.21

Zevra Therapeutics's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (0	+	12.487)	/	1 )	/	1.304	*	365 / 4
=	12.487					/	1.304	*	365 / 4
=	873.80

Zevra Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Zevra Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Zevra Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zevra Therapeutics Inc (FRA:1GDA) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

ZVRA:USA 1GDA:Germany

Address

1180 Celebration Boulevard, Suite 103, Celebration, FL, USA, 34747

Website

https://www.zevra.com

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Zevra Therapeutics Headlines

No Headlines